Dr. Phillip Kallen, M.D.
What this data tells you about Dr. Kallen
Dr. Phillip Kallen is a rheumatology in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kallen performed 11,881 Medicare services across 2,057 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kallen received a total of $5,879 from 32 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kallen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 7,080 | $18 | $25 |
| Steroid injection (triamcinolone) | 713 | $1 | $10 |
| Office visit, established patient (30-39 min) | 348 | $97 | $150 |
| Blood draw (venipuncture) | 314 | $8 | $10 |
| Calcium level, total | 255 | $5 | $8 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 205 | $60 | $100 |
| Blood creatinine level | 186 | $5 | $12 |
| Urea nitrogen level to assess kidney function, quantitative | 186 | $4 | $12 |
| Phosphatase (enzyme) level, alkaline | 183 | $5 | $15 |
| Liver enzyme (sgot), level | 183 | $5 | $15 |
| Liver enzyme (sgpt), level | 183 | $5 | $15 |
| C-reactive protein test (inflammation marker) | 183 | $5 | $12 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 181 | $4 | $12 |
| Albumin (protein) level | 180 | $5 | $8 |
| Bilirubin level, total | 180 | $5 | $12 |
| Complete blood count (CBC) with differential | 157 | $8 | $31 |
| Blood sodium level | 141 | $5 | $12 |
| Blood potassium level | 140 | $5 | $8 |
| Office visit, established patient (20-29 min) | 138 | $67 | $100 |
| Vitamin D level test | 136 | $29 | $55 |
| Uric acid level test | 135 | $4 | $8 |
| Joint injection, major joint | 92 | $48 | $133 |
| Office visit, established patient, complex (40-54 min) | 84 | $141 | $200 |
| Bone density scan (DEXA) | 71 | $39 | $125 |
| Analysis of substance using immunoassay technique, multiple step method | 46 | $11 | $20 |
| X-ray of hand, minimum of 3 views | 29 | $31 | $50 |
| Complete blood count (CBC), automated | 28 | $6 | $18 |
| Knee X-ray, 3 views | 27 | $34 | $55 |
| Screening test for autoimmune disorder | 27 | $12 | $25 |
| Measurement of antibody for rheumatoid arthritis assessment | 25 | $13 | $25 |
| Rheumatoid factor level | 23 | $6 | $25 |
| New patient office visit (45-59 min) | 11 | $114 | $225 |
| New patient office visit, complex (60-74 min) | 11 | $179 | $285 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kallen is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kallen experienced with denosumab injection (prolia/xgeva)?
Does Dr. Kallen receive payments from pharmaceutical companies?
How do Dr. Kallen's costs compare to other rheumatologys in Delray Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology